LoginGet started
Picture of Formosa Laboratories logo

4746 — Formosa Laboratories Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Formosa Laboratories, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-40.23611,088333142
Depreciation
Amortisation
Non-Cash Items55.5-305-1,246-126450
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-110-31.1-5.34-35.5-254
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities290475311643827
Capital Expenditures-1,421-1,011-514-440-541
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-58.7150-75.7-101-717
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,480-861-589-541-1,257
Financing Cash Flow Items0161532272584
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities773516439448700
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-418127149550247